SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 116 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2014. The put-call ratio across all filers is 2.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $123,161,000 | +28.5% | 1,262,798 | +22.3% | 0.03% | +26.9% |
| Q4 2014 | $95,824,000 | +47.6% | 1,032,698 | +9.4% | 0.03% | +44.4% |
| Q3 2014 | $64,908,000 | -34.4% | 943,698 | 0.0% | 0.02% | -33.3% |
| Q2 2014 | $98,900,000 | +15.9% | 943,698 | -8.2% | 0.03% | +12.5% |
| Q1 2014 | $85,326,000 | +142.0% | 1,028,398 | +88.8% | 0.02% | +140.0% |
| Q4 2013 | $35,253,000 | +5.1% | 544,700 | +2.8% | 0.01% | 0.0% |
| Q3 2013 | $33,554,000 | +255.1% | 530,000 | +135.6% | 0.01% | +233.3% |
| Q2 2013 | $9,450,000 | – | 225,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|